Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, announced that Fitch Ratings has upgraded Bio-Rad Laboratories, Inc.’s Long-Term Issuer-Default to “BBB” from “BBB-.” The upgrade reflects Bio-Rad’s improved EBITDA and FCF margins, which, according to Fitch Ratings, are trending toward industry averages as a result of cost rationalization initiatives …

source https://finance.yahoo.com/news/fitch-ratings-upgrades-bio-rad-225600331.html?.tsrc=rss